IMS Health Study Forecasts Global Spending on Medicines to Increase 30 Percent by 2018, to $1.3 Trillion
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies
LONDON and NEW YORK, November 19, 2014 /PRNewswire/ --
First Long-Acting Treatment to be Used Four Times a Year for Schizophrenia in Adults
TITUSVILLE, N.J., Nov.
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
New data show dabigatran-specific antidote idarucizumab* restores blood clotting mechanism in humans
Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent
THOUSAND OAKS, Calif.
European Commission Grants Marketing Authorization for Gilead's Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4
New retrospective data showed empagliflozin reduced A1C, body weight and markers of abdominal fat in adults with type 2 diabetes
- Jardiance® (empagliflozin) data results presented at the 2014 Scientific Sessions of the American Heart Association
People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes
New research in the international medical journal CHEST showed patients had reduced hospital stays, medical costs and returns to the hospital
ABBOTT PARK, Ill.,